|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [725]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [725]
National Comorbidity Survey. Experimental and Clinical Psychopharmacology, 2, 244–268.
Arthur, M. W., Ayers, C. D., Graham, K. A., & Hawkins, J. D. (2003). Mobilizing communities to reduce risks for drug abuse: A comparison of two strategies. In W. J. Bukoski & Z. Sloboda (Eds.), Handbook of drug abuse theory, science and practice (pp. 129–144). New York: Plenum Press.
Aydin, K., Sencer, S., Demir, T., Ogel, K., Tunaci, A., & Minareci, O. (2002). Cranial MR findings in chronic toluene abuse by inhalation. American Journal of Neuroradiology, 23, 1173–1179.
Azrin, N. H., Donohue, B., & Besalel, V. A. (1994). Youth drug abuse treatment: A controlled outcome study. Journal of Child and Adolescent Substance Abuse, 3, 1–16.
Bachman, J. G., Johnston, L. D., & O'Malley, P. M. (1998). Explaining the recent increases in students' marijuana use: The impacts of perceived risks and disapproval from 1976 through 1996. American Journal of Public Health, 88, 887–892.
Baer, J. S. (1993). Etiology and secondary prevention of alcohol problems with young adults. In J. S. Baer, G. A. Marlatt, & R. J. McMahon (Eds.), Addictive behaviors across the life span: Prevention, treatment, and policy issues (pp. 111–137). Newbury Park, CA: Sage Publications.
Barrickman, L. L., Perry, P. J., Allen, A. J., Kuperman, S., Arndt, S. V., Herrmann, K. J., et al. (1995). Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 649–657.
Beauvais, F., Wayman, J. C., Jumper-Thurman, P., Plested, B., & Helm, H. (2002). Inhalant abuse among American Indian, Mexican American,
and non-Latino white adolescents. American Journal of Drug and Alcohol Abuse, 28, 171–187.
Benowitz, N. L. (1990). Pharmacokinetic considerations in understanding nicotine dependence. In G. Block & J. Marsh (Eds.), The biology of nicotine dependence (Vol. Ciba Foundation Symposium 152, pp. 186–209). Chichester: John Wiley & Sons.
Benowitz, N. L., & Jacob, P., III. (1999). Pharmacokinetics and metabolism of nicotine and related alkaloids. In S. P. Arneric & J. D. Brioni (Eds.), Neuronal nicotinic receptors (pp. 213–234). New York: Wiley-Liss.
Benowitz, N. L., Perez-Stable, E. J., Herrera, B., & Jacob, P., 3rd. (2002). Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. Journal of the National Cancer Institute, 94, 108–115.
Bergen, A. W., Korczak, J. F., Weissbecker K. A., Goldstein, A. M., et al. (1999). A genome-wide search for loci contribution to smoking and alcoholism. Genetic Epidemiology, 17, S55–60.
Berrettini, W. H., Alexander, R., Ferraro, T. N., & Vogel, W. H. (1994). A study of oral morphine preference in inbred mouse strains. Psychiatric Genetics, 4, 81–86.
Biederman, J., Wilens, T., Mick, E., Faraone, S. V., Weber, W., Curtis, S., et al. (1997). Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 21–29.
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999). Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics, 104, e20.
Bieurt, L., Rice, J., Edenberg, H., Goate, A., Foroud, T., & Cloninger, C. (2000). Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. American Journal of Medical Genetics, 90, 299–302.
Bierut, L. J., Saccone, N. L., Rice, J. P., Goate, A., Foroud, T., Edenberg, H., et al. (2002). Defining alcohol-related phenotypes in humans. The Collaborative Study on the Genetics of Alcoholism. Alcohol Research and Health, 26, 208–213.
Bigelow, G. E., Stitzer, M. L., & Liebson, I. A. (1984). The role of behavioral contingency man
end p.725
|
|
|
|
